# A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food

> **NCT05498701** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tafamidis free acid tablet (Test)
- **DRUG:** Tafamidis meglumine capsule (Reference)

## Key facts

- **NCT ID:** NCT05498701
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-29
- **Primary completion:** 2022-12-18
- **Final completion:** 2022-12-19
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05498701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05498701, "A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food". Retrieved via MORVS 2026-10-08 from https://api.morvs.ai/clinical/NCT05498701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*